Tri Locum Partners’s Exelixis EXEL Stock Holding History

Tri Locum Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-329,068	Closed	-$7.46M	–	54
2022 Q1	$7.46M	Buy	+329,068	New	+$6.43M	2.91%	17

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tri Locum Partners's EXEL Position: Q2 2022 in Review

Tri Locum Partners sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 329,068 shares — an estimated $7.46M sold.

Tri Locum Partners first reported a position in EXEL in Q1 2022 and held it in 1 quarter. The position peaked at $7.46M in Q1 2022. 373 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

Tri Locum Partners reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
Tri Locum Partners sold 329,068 Exelixis shares in Q2 2022, an estimated $7.46M.
Tri Locum Partners first reported a position in Exelixis in Q1 2022 and held it in 1 quarter.
Tri Locum Partners's Exelixis position peaked at $7.46M in Q1 2022.
373 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on Tri Locum Partners's 13F filing for Q2 2022, filed 15 Aug 2022.